Last synced on 25 November 2022 at 11:04 pm

Laser, Benign Prostatic Hyperplasia

Page Type
Product Code
Definition
Laser ablation of prostatic tissue for the treatment of benign prostatic hyperplasia
Physical State
The device consists primarily of medical laser and deliver fibers. The fibers are positioned in the prostate or prostatic urethra through endoscopy and direct laser optical energy into the prostate.
Technical Method
Laser optical energy is applied to the prostate using endoscopically delivered fibers. Heating of the prostatic tissue leads to necrotic death or direct ablation depending on the temperatures achieved.
Target Area
Prostate
Regulation Medical Specialty
General and Plastic Surgery
Review Panel
General and Plastic Surgery
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
878.4810
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a) Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.

(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

(b) Classification. (1) Class II.

(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

[53 FR 23872, June 24, 1988, as amended at 61 FR 1123, Jan. 16, 1996; 66 FR 38803, July 25, 2001]

Laser, Benign Prostatic Hyperplasia

Page Type
Product Code
Definition
Laser ablation of prostatic tissue for the treatment of benign prostatic hyperplasia
Physical State
The device consists primarily of medical laser and deliver fibers. The fibers are positioned in the prostate or prostatic urethra through endoscopy and direct laser optical energy into the prostate.
Technical Method
Laser optical energy is applied to the prostate using endoscopically delivered fibers. Heating of the prostatic tissue leads to necrotic death or direct ablation depending on the temperatures achieved.
Target Area
Prostate
Regulation Medical Specialty
General and Plastic Surgery
Review Panel
General and Plastic Surgery
Submission Type
510(K)
Device Classification
Class 2
Regulation Number
878.4810
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

CFR § 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a) Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.

(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

(b) Classification. (1) Class II.

(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

[53 FR 23872, June 24, 1988, as amended at 61 FR 1123, Jan. 16, 1996; 66 FR 38803, July 25, 2001]